{\rtf1\ansi\ansicpg1252\cocoartf2580
\cocoatextscaling0\cocoaplatform0{\fonttbl\f0\fswiss\fcharset0 Helvetica;}
{\colortbl;\red255\green255\blue255;}
{\*\expandedcolortbl;;}
\paperw11900\paperh16840\margl1440\margr1440\vieww11520\viewh8400\viewkind0
\pard\tx566\tx1133\tx1700\tx2267\tx2834\tx3401\tx3968\tx4535\tx5102\tx5669\tx6236\tx6803\pardirnatural\partightenfactor0

\f0\fs24 \cf0 <!DOCTYPE html>\
<html lang="en">\
<head>\
    <meta charset="UTF-8">\
    <meta name="viewport" content="width=device-width, initial-scale=1.0">\
    <title>Top 15 Pharma & Biotech M&A Deals of 2025</title>\
    <style>\
        body \{\
            font-family: Arial, sans-serif;\
            margin: 20px;\
            background-color: #f4f4f4;\
        \}\
        table \{\
            width: 100%;\
            border-collapse: collapse;\
            background-color: #fff;\
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);\
        \}\
        th, td \{\
            padding: 12px;\
            text-align: left;\
            border-bottom: 1px solid #ddd;\
        \}\
        th \{\
            background-color: #4a90e2;\
            color: white;\
        \}\
        tr:nth-child(even) \{\
            background-color: #f8f8f8;\
        \}\
        tr:hover \{\
            background-color: #e0e0e0;\
        \}\
        caption \{\
            font-size: 1.5em;\
            font-weight: bold;\
            margin-bottom: 10px;\
            color: #333;\
        \}\
        a \{\
            color: #0066cc;\
            text-decoration: none;\
        \}\
        a:hover \{\
            text-decoration: underline;\
        \}\
    </style>\
</head>\
<body>\
    <table>\
        <caption>Top 15 Pharma & Biotech M&A Deals of 2025 (in USD Billion)</caption>\
        <tr>\
            <th>Acquiring Company</th>\
            <th>Acquired Company</th>\
            <th>Value (USD Billion)</th>\
        </tr>\
        <tr>\
            <td>Novo Holdings</td>\
            <td>Catalent</td>\
            <td><a href="https://www.catalent.com/catalent-news/novo-holdings-to-acquire-catalent/" target="_blank">$16.50B</a></td>\
        </tr>\
        <tr>\
            <td>Gilead</td>\
            <td>CymaBay</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$4.30B</a> <sup>*</sup></td>\
        </tr>\
        <tr>\
            <td>Sinopharm</td>\
            <td>[Not specified]</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$3.00B</a> <sup>*</sup></td>\
        </tr>\
        <tr>\
            <td>Novartis</td>\
            <td>MorphoSys</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$2.90B</a> <sup>*</sup></td>\
        </tr>\
        <tr>\
            <td>Roquette</td>\
            <td>IFF Pharma Solutions</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$2.85B</a> <sup>*</sup></td>\
        </tr>\
        <tr>\
            <td>AstraZeneca</td>\
            <td>Fusion</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$2.41B</a> <sup>*</sup></td>\
        </tr>\
        <tr>\
            <td>Sanofi</td>\
            <td>Inhibrx</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$2.20B</a> <sup>*</sup></td>\
        </tr>\
        <tr>\
            <td>Johnson & Johnson</td>\
            <td>Ambrx</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$2.00B</a> <sup>*</sup></td>\
        </tr>\
        <tr>\
            <td>ALPS</td>\
            <td>Globelink</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$1.60B</a> <sup>*</sup></td>\
        </tr>\
        <tr>\
            <td>GSK</td>\
            <td>Aiolos Bio</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$1.40B</a> <sup>*</sup></td>\
        </tr>\
        <tr>\
            <td>MSD Animal Health</td>\
            <td>Elanco</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$1.30B</a> <sup>*</sup></td>\
        </tr>\
        <tr>\
            <td>Lonza</td>\
            <td>GeneTech</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$1.20B</a> <sup>*</sup></td>\
        </tr>\
        <tr>\
            <td>Cardinal Health</td>\
            <td>Specialty Networks</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$1.20B</a> <sup>*</sup></td>\
        </tr>\
        <tr>\
            <td>Novo Nordisk</td>\
            <td>Cardior</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$1.11B</a> <sup>*</sup></td>\
        </tr>\
        <tr>\
            <td>AstraZeneca</td>\
            <td>AmolyT Pharma</td>\
            <td><a href="https://example.com/acquisition-news" target="_blank">$1.05B</a> <sup>*</sup></td>\
        </tr>\
    </table>\
    <p><sup>*</sup> No specific announcement link available from provided data. Replace with actual news source URL if available.</p>\
</body>\
</html>}